← Scroll for more →
Relmada Therapeutics, Inc. (RLMD)
Pharmaceutical Preparations
Latest Price
$3.21
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.97
P/B Ratio
1.63
Institutional Ownership
94.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 11.16M | $77.0M | 10.47% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.43M | $51.0M | 6.96% | +6.14M | 2026-06-30 |
| Squadron Capital Management LLC | 7.35M | $50.0M | 6.89% | -1.12M | 2026-06-30 |
| Venrock Adviser, LLC | 6.84M | $47.0M | 6.42% | +2.00M | 2026-06-30 |
| Spruce Street Capital LP | 6.39M | $44.0M | 5.99% | +129.2K | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 4.76M | $32.0M | 4.47% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.46M | $30.0M | 4.18% | +1.38M | 2026-06-30 |
| Jones Hill Capital LP | 3.66M | $25.0M | 3.43% | +3.31M | 2026-06-30 |
| Orbimed Advisors LLC | 3.63M | $25.0M | 3.40% | -1.08M | 2026-06-30 |
| State Street Corp | 2.52M | $17.0M | 2.36% | +2.16M | 2026-06-30 |